Results 11 to 20 of about 3,788,205 (194)

Clinical epidemiology of epithelial ovarian cancer in the UK

open access: yesInternational Journal of Women's Health, 2014
Konstantinos Doufekas, Adeola OlaitanDepartment of Gynaecological Oncology, University College London Hospitals, London, UKAbstract: Epithelial ovarian cancer is the fifth commonest cancer among women and the leading cause of gynecological cancer death ...
Doufekas K, Olaitan A
doaj   +1 more source

Epithelial Ovarian Cancer [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2011
Chapter Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189 Primary Chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190 Early-Stage Disease . . . . . . . . . .
Robert J, Morgan   +23 more
  +5 more sources

Investigating the impact of NHS based ovarian cancer screening [PDF]

open access: yes, 2010
the UK ovarian cancer is the fifth most common cancer in females and after uterine cancer, the second most common gynaecological cancer. There were 6,596 new cases diagnosed in the UK in 2006.
Nicholson, S. M.
core   +7 more sources

Epithelial ovarian cancer [PDF]

open access: yesThe Lancet, 2019
Epithelial ovarian cancer generally presents at an advanced stage and is the most common cause of gynaecological cancer death. Treatment requires expert multidisciplinary care. Population-based screening has been ineffective, but new approaches for early diagnosis and prevention that leverage molecular genomics are in development.
S, Lheureux   +3 more
openaire   +3 more sources

Investigating the potential for expediting diagnosis of ovarian cancer via prompt symptom recognition & "targeted screening" [PDF]

open access: yes, 2009
PhDThis thesis explores the potential for using symptoms as a tool to bring forward the diagnosis of ovarian cancer. Current evidence supports the existence of prediagnostic symptoms, however symptom lead time has yet to be adequately quantified ...
Lim, Anita Wey Wey
core   +4 more sources

Focus on epithelial ovarian cancer [PDF]

open access: yesCancer Cell, 2004
Epithelial ovarian cancer (EOC) will be diagnosed in 24,400women in the United States in 2004, with an estimated 14,300deaths (Jemal et al., 2003).Neoplasms from the surface epithe-lium of the ovary exhibit a variety of Mullerian-type cells, includ-ing serous, mucinous, endometrioid, and clear cell, reflecting acommon pathway in embryological ...
Ozols, Robert F.   +7 more
openaire   +2 more sources

Epidemiology of epithelial ovarian cancer [PDF]

open access: yesBest Practice & Research Clinical Obstetrics & Gynaecology, 2017
Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. Although age-standardised rates are stable or falling in most high-income countries, they are rising in many low and middle income countries.
Penelope M. Webb, Susan J. Jordan
openaire   +4 more sources

Treatment of epithelial ovarian cancer [PDF]

open access: yesBMJ, 2020
ABSTRACTOvarian cancer is the third most common gynecologic malignancy worldwide but accounts for the highest mortality rate among these cancers. A stepwise approach to assessment, diagnosis, and treatment is vital to appropriate management of this disease process.
Kuroki, Lindsay, Guntupalli, Saketh R
openaire   +3 more sources

Animal models of ovarian cancer. [PDF]

open access: yes, 2003
Ovarian cancer is the most lethal of all of the gynecological cancers and can arise from any cell type of the ovary, including germ cells, granulosa or stromal cells.
Jean-François Ethier   +11 more
core   +1 more source

Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer

open access: yesAnnals of Oncology, 2016
Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide, despite gains in diagnostics and treatments made over the last three decades. Existing markers of ovarian cancer possess very limited clinical relevance highlighting the emerging need for identification of novel prognostic biomarkers as ...
Krzystyniak J.   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy